Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Change in Inventory (2016 - 2025)

CorMedix's Change in Inventory history spans 10 years, with the latest figure at $800120.0 for Q4 2025.

  • For Q4 2025, Change in Inventory fell 15.76% year-over-year to $800120.0; the TTM value through Dec 2025 reached $3.5 million, down 36.68%, while the annual FY2025 figure was $3.5 million, 36.68% down from the prior year.
  • Change in Inventory for Q4 2025 was $800120.0 at CorMedix, up from $642977.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $2.6 million in Q3 2024 and bottomed at -$111827.0 in Q1 2025.
  • The 4-year median for Change in Inventory is -$331.5 (2022), against an average of $551408.5.
  • The largest annual shift saw Change in Inventory crashed 419.97% in 2021 before it surged 99.41% in 2022.
  • A 4-year view of Change in Inventory shows it stood at -$45910.0 in 2021, then soared by 99.41% to -$269.0 in 2022, then soared by 353204.09% to $949850.0 in 2024, then decreased by 15.76% to $800120.0 in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Change in Inventory are $800120.0 (Q4 2025), $642977.0 (Q3 2025), and $2.1 million (Q2 2025).